Canadian perspectives in glaucoma management: setting target intraocular pressure range

Can J Ophthalmol. 2003 Apr;38(3):189-97. doi: 10.1016/s0008-4182(03)80060-1.


There is an abundance of evidence from recent randomized clinical trials showing that lowering the IOP is beneficial to the optic nerve and visual field. Setting and achieving a target IOP range is in keeping with evidence-based medicine. The benefits of reaching this target must be weighed against the risks of the treatment itself. Target IOP is a dynamic concept, needing constant reevaluation. What is lacking are established guidelines for determining the target IOP range that can be used in general ophthalmology practice.

Publication types

  • Consensus Development Conference
  • Guideline
  • Practice Guideline
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Antihypertensive Agents / therapeutic use
  • Blindness / prevention & control
  • Canada
  • Evidence-Based Medicine*
  • Glaucoma, Open-Angle / therapy*
  • Humans
  • Intraocular Pressure*
  • Optic Nerve Diseases / prevention & control
  • Randomized Controlled Trials as Topic
  • Reference Values
  • Trabeculectomy


  • Antihypertensive Agents